Literature DB >> 21849896

Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking.

Bettina Mittendorfer1.   

Abstract

PURPOSE OF REVIEW: Obesity is associated with a number of serious medical complications that are risk factors for cardiovascular disease (e.g., insulin resistance, dyslipidemia, and liver fat accumulation). Alterations in fatty acid trafficking, both between tissues and within cells, represent a key feature in the pathophysiology of the metabolic complications in obese patients. The ways by which fatty acid 're-routing' may affect metabolic function are summarized in this article. RECENT
FINDINGS: Ectopic fat accumulation (i.e., fat accumulation in nonadipose tissues) appears to be a key feature distinguishing metabolically healthy from metabolically abnormal patients. This observation has led to the belief that an imbalance in fatty acid trafficking away from adipose tissue toward nonadipose tissues is a primary cause for the development of metabolic alterations in obese patients. More recently, however, it has become apparent that fatty acid trafficking within nonadipose tissues cells (i.e., toward storage - in the form of triglycerides - and oxidation) may be equally important in determining a person's risk for development of metabolic disease.
SUMMARY: The pathophysiology of the metabolic alterations associated with obesity is probably multifactorial within a complex network of coordinated physiological responses. Only through the integration of multiple concepts, will it be possible to further our understanding in this area and to help prevent the metabolic alterations associated with obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849896      PMCID: PMC3711689          DOI: 10.1097/MCO.0b013e32834ad8b6

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  88 in total

1.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

Review 2.  Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.

Authors:  Michael D Jensen
Journal:  Obesity (Silver Spring)       Date:  2006-02       Impact factor: 5.002

3.  Skeletal muscle triglyceride levels are inversely related to insulin action.

Authors:  D A Pan; S Lillioja; A D Kriketos; M R Milner; L A Baur; C Bogardus; A B Jenkins; L H Storlien
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

Review 4.  Fatty acid signaling in the beta-cell and insulin secretion.

Authors:  Christopher J Nolan; Murthy S R Madiraju; Viviane Delghingaro-Augusto; Marie-Line Peyot; Marc Prentki
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

Review 5.  Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective.

Authors:  Sam Virtue; Antonio Vidal-Puig
Journal:  Biochim Biophys Acta       Date:  2010-01-06

6.  Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality.

Authors:  Abel Romero-Corral; Virend K Somers; Justo Sierra-Johnson; Yoel Korenfeld; Simona Boarin; Josef Korinek; Michael D Jensen; Gianfranco Parati; Francisco Lopez-Jimenez
Journal:  Eur Heart J       Date:  2009-11-20       Impact factor: 29.983

7.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

8.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.

Authors:  Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

9.  Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.

Authors:  Hélène Duez; Benoît Lamarche; René Valéro; Mirjana Pavlic; Spencer Proctor; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

10.  Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?

Authors:  Siobhán E McQuaid; Leanne Hodson; Matthew J Neville; A Louise Dennis; Jane Cheeseman; Sandy M Humphreys; Toralph Ruge; Marjorie Gilbert; Barbara A Fielding; Keith N Frayn; Fredrik Karpe
Journal:  Diabetes       Date:  2010-10-13       Impact factor: 9.461

View more
  45 in total

1.  Impact of miR-140 Deficiency on Non-Alcoholic Fatty Liver Disease.

Authors:  Benjamin Wolfson; Pang-Kuo Lo; Yuan Yao; Linhao Li; Hongbing Wang; Qun Zhou
Journal:  Mol Nutr Food Res       Date:  2018-06-12       Impact factor: 5.914

2.  Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.

Authors:  Uche Ezeh; Zorayr Arzumanyan; Daria Lizneva; Ruchi Mathur; Yen-Hao Chen; Raymond C Boston; Y-D Ida Chen; Ricardo Azziz
Journal:  Hum Reprod       Date:  2019-02-01       Impact factor: 6.918

3.  Adipose tissue autophagy related gene expression is associated with glucometabolic status in human obesity.

Authors:  Qing Xu; Edwin C M Mariman; Nadia J T Roumans; Roel G Vink; Gijs H Goossens; Ellen E Blaak; Johan W E Jocken
Journal:  Adipocyte       Date:  2018-02-05       Impact factor: 4.534

Review 4.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

5.  Inhibition of adipose tissue PPARγ prevents increased adipocyte expansion after lipectomy and exacerbates a glucose-intolerant phenotype.

Authors:  A D Booth; A M Magnuson; K A Cox-York; Y Wei; D Wang; M J Pagliassotti; M T Foster
Journal:  Cell Prolif       Date:  2016-12-15       Impact factor: 6.831

Review 6.  Non-invasive Assessments of Adipose Tissue Metabolism In Vitro.

Authors:  Rosalyn D Abbott; Francis E Borowsky; Kyle P Quinn; David L Bernstein; Irene Georgakoudi; David L Kaplan
Journal:  Ann Biomed Eng       Date:  2015-09-23       Impact factor: 3.934

Review 7.  Immunologic and endocrine functions of adipose tissue: implications for kidney disease.

Authors:  Qingzhang Zhu; Philipp E Scherer
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

Review 8.  G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis.

Authors:  Geetanjali Sharma; Eric R Prossnitz
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 9.  Insulin resistance in obesity: an overview of fundamental alterations.

Authors:  Rocco Barazzoni; Gianluca Gortan Cappellari; Maurizio Ragni; Enzo Nisoli
Journal:  Eat Weight Disord       Date:  2018-02-03       Impact factor: 4.652

10.  Unchanged mitochondrial phenotype, but accumulation of lipids in the myometrium in obese pregnant women.

Authors:  Christiane Marie Bourgin Folke Gam; Lea Hüche Larsen; Ole Hartvig Mortensen; Line Engelbrechtsen; Steen Seier Poulsen; Klaus Qvortrup; Elisabeth Reinhart Mathiesen; Peter Damm; Bjørn Quistorff
Journal:  J Physiol       Date:  2017-11-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.